These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9054864)

  • 1. Persistent inhibition of platelets during continuous nitroglycerin therapy despite hemodynamic tolerance.
    Hébert D; Xiang JX; Lam JY
    Circulation; 1997 Mar; 95(5):1308-13. PubMed ID: 9054864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitroglycerin rebound associated with vascular, rather than platelet, hypersensitivity.
    Hébert D; Lam JY
    J Am Coll Cardiol; 2000 Dec; 36(7):2311-6. PubMed ID: 11127478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained antiplatelet properties of nitroglycerin during hemodynamic tolerance in rats.
    Booth BP; Jacob S; Bauer JA; Fung HL
    J Cardiovasc Pharmacol; 1996 Sep; 28(3):432-8. PubMed ID: 8877591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylene blue inhibits the antithrombotic effect of nitroglycerin.
    Johnstone MT; Lam JY; Lacoste L; Baribeau J; Théroux P; Waters D
    J Am Coll Cardiol; 1993 Jan; 21(1):255-9. PubMed ID: 8093254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet nitric oxide and superoxide release during the development of nitrate tolerance: effect of supplemental ascorbate.
    McVeigh GE; Hamilton P; Wilson M; Hanratty CG; Leahey WJ; Devine AB; Morgan DG; Dixon LJ; McGrath LT
    Circulation; 2002 Jul; 106(2):208-13. PubMed ID: 12105160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet function is inhibited by nitric oxide liberation during nitroglycerin-induced hypotension anaesthesia.
    Aoki H; Inoue M; Mizobe T; Harada M; Imai H; Kobayashi A
    Br J Anaesth; 1997 Oct; 79(4):476-81. PubMed ID: 9389267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet cyclic GMP responses to nitroglycerin.
    Martin DD; Tong JS; Parker JD
    Cardiovasc Drugs Ther; 2000 Aug; 14(4):419-25. PubMed ID: 10999649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parallel tolerance between platelet cyclic GMP and preload effects of nitroglycerin in anaesthetized mini-pigs.
    Baines CP; Szwarc RS; Ball HA
    Br J Pharmacol; 1994 Oct; 113(2):334-5. PubMed ID: 7834179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive effects of angiotensin-converting enzyme inhibitors on nitrate tolerance during continuous transdermal application of nitroglycerin in patients with chronic heart failure.
    Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
    Jpn Circ J; 1998 May; 62(5):353-8. PubMed ID: 9626903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of peroxynitrite decomposition catalyst MnTBAP on aldehyde dehydrogenase-2 nitration by organic nitrates: role in nitrate tolerance.
    Mollace V; Muscoli C; Dagostino C; Giancotti LA; Gliozzi M; Sacco I; Visalli V; Gratteri S; Palma E; Malara N; Musolino V; Carresi C; Muscoli S; Vitale C; Salvemini D; Romeo F
    Pharmacol Res; 2014 Nov; 89():29-35. PubMed ID: 25174989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
    Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
    J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure.
    Tsutamoto T; Kinoshita M; Hisanaga T; Maeda Y; Maeda K; Wada A; Fukai D; Yoshida S
    Am J Cardiol; 1995 Jun; 75(16):1162-5. PubMed ID: 7762505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between vascular tolerance and platelet upregulation: comparison of nonintermittent administration of pentaerithrityltetranitrate and glyceryltrinitrate.
    Fink B; Bassenge E
    J Cardiovasc Pharmacol; 2002 Dec; 40(6):890-7. PubMed ID: 12451322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The acute, chronic continuous after treatment and chronic intermittent with a variable therapeutic window (4 and 6 hours) hemodynamic effects induced with transdermal nitroglycerin in patients with congestive heart failure].
    Nodari S; Metra M; Gei P; Danesi R; Furloni R; Cuminetti S; Dei Cas L
    Cardiologia; 1991 Jun; 36(6):451-60. PubMed ID: 1769029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance to nitrates and simultaneous upregulation of platelet activity prevented by enhancing antioxidant state.
    Bassenge E; Fink B
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):363-7. PubMed ID: 8692294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic properties of transdermal nitroglycerin in stable angina pectoris.
    Lacoste LL; Théroux P; Lidón RM; Colucci R; Lam JY
    Am J Cardiol; 1994 Jun; 73(15):1058-62. PubMed ID: 8198030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta.
    Mülsch A; Oelze M; Klöss S; Mollnau H; Töpfer A; Smolenski A; Walter U; Stasch JP; Warnholtz A; Hink U; Meinertz T; Münzel T
    Circulation; 2001 May; 103(17):2188-94. PubMed ID: 11331261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitroglycerin tolerance at the platelet level in patients with angina pectoris.
    Chirkov YY; Chirkova LP; Horowitz JD
    Am J Cardiol; 1997 Jul; 80(2):128-31. PubMed ID: 9230146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term smoking causes nitroglycerin resistance in platelets by depletion of intraplatelet glutathione.
    Haramaki N; Ikeda H; Takajo Y; Katoh A; Kanaya S; Shintani S; Haramaki R; Murohara T; Imaizumi T
    Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1852-6. PubMed ID: 11701477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard versus low-dose transdermal nitroglycerin: differential effects on the development of tolerance and abnormalities of endothelial function.
    Uxa A; Thomas GR; Gori T; Parker JD
    J Cardiovasc Pharmacol; 2010 Oct; 56(4):354-9. PubMed ID: 20588187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.